The week at Retraction Watch featured a look at retractions in China, and an expression of concern for a paper co-authored by a controversial journalist in Australia. Here’s what was happening elsewhere:
After reviewing nearly 20 years of retractions from researchers based in China, researchers came up with some somewhat unsurprising (yet still disheartening) findings: The number of retractions has increased (from zero in 1997 to more than 150 in 2016), and approximately 75% were due to some kind of misconduct. (You can read more details in … Continue reading 20 years of retractions in China: More of them, and more misconduct
The University of Copenhagen has stripped Milena Penkowa of her doctoral degree, after determining she had covered up problems with her research. According to a release issued today by the university, Penkowa falsified documents to allay suspicions that she had not performed some animal experiments as she’d reported. This development is the latest in a … Continue reading Copenhagen revokes degree of controversial neuroscientist Milena Penkowa
The week at Retraction Watch featured a battle over psychologists and torture, a case of misconduct at Harvard, allegations of bribery, and a lawsuit against the New York Times. Here’s what was happening elsewhere:
Carlo Croce, a cancer researcher at The Ohio State University who has faced numerous allegations of research misconduct, has filed a lawsuit against the New York Times, claiming the newspaper defamed him in a March 8 story. Croce filed the civil suit May 10, in the US District Court for the Southern District of Ohio, … Continue reading Carlo Croce, Ohio State researcher facing misconduct allegations, suing New York Times for defamation
The week at Retraction Watch featured the retraction of a paper from Yale on ketamine and depression, a retraction for Carlo Croce, and a discussion of when a citation may not be enough. Here’s what was happening elsewhere:
SAGE recently retracted three 2015 papers from one of its journals after the publisher found the articles were accepted with faked peer reviews. The retraction notices call out the authors responsible for submitting the reviews. This trio of retractions is the second batch of papers withdrawn by Technology in Cancer Research & Treatment over faked … Continue reading SAGE journal retracts three more papers after discovering faked reviews
A company that indexes journals — thereby assigning them impact factors — has chosen to delist a cancer journal after it retracted 107 papers earlier this year for faked peer reviews. Starting July 19, anything published by Tumor Biology will not be indexed in Web of Science, part of Clarivate Analytics (formerly part of Thomson … Continue reading When a journal retracts 107 papers for fake reviews, it pays a price
A professor at Sunchon National University has resigned from a prominent government position in South Korea after facing heavy criticism for being a co-author of a fraudulent stem cell paper. Earlier this week, President Moon Jae-in appointed Park Ky-young to run a newly created Science, Technology and Innovation Office at the Ministry of Science and ICT. … Continue reading Scientist steps down from South Korea government position over criticism of her role in stem cell scandal
A recent pre-print showed that scientists in China can earn up to $165,000 to publish a paper in a top journal, but that’s not the only place where researchers can get some extra cash. Recently, we conducted an informal search for other institutions around the world that offer cash prizes for publishing research — and … Continue reading Paid to publish: It’s not just China